Table 1: Patients affected by change in risk stratification.
| Female sex (n = 4) | Male sex (n = 9) | |
| Prepubertal | 50% (2/4) | 55% (5/9) |
| Low-significant risk change | 50% (2/4) | 0 |
| Intermediate-high risk change | 50% (2/4) | 55.5% (5/9) |
| Low-high risk change | 0 | 44.4% (4/9) |
| Diagnoses | Neuroblastoma (1) | Lymphoma (5) |
| T cell Lymphoma (1) | Neuroblastoma (1) | |
| Rhabdosarcoma (1) | Osteosarcoma (2) | |
| Osteosarcoma (1) | Relapsed all (1) | |
| Fertility preservation | ||
| Completed prior to treatment | 0/4 | 2/9 |
| Declined prior to treatment | 3/4 | 2/9 |
| Not eligible for FP prior to treatment∗ | 1/4 | 5/9 |
| ∗The patient was not eligible by prior criteria, but by new criteria, the patient would have been eligible for experimental FP protocols. | ||